Using high-throughput genomics to study hepatitis C: what determines the outcome of infection?

Antiviral Research
Kathie-Anne Walters, Michael G Katze

Abstract

High-throughput genomic methods are now being used to study a wide variety of viral diseases, in an effort to understand how host responses to infection can lead either to efficient elimination of the pathogen or the development of severe disease. This article reviews how gene expression studies are addressing important clinical issues related to hepatitis C virus infection, in which some 15-25% of infected individuals are able to clear the virus without treatment, while the remainder progress to chronic liver disease that can lead to cirrhosis and death. Similar methods are also being used in an effort to identify the mechanisms underlying the failure of some hepatitis C patients to respond to interferon-alpha/ribavirin therapy. By providing a detailed picture of virus-host interactions, high-throughput genomics could potentially lead to the identification of novel cellular targets for the treatment of hepatitis C.

References

Jun 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N HiramatsuT Kamada
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D T LauJ H Hoofnagle
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y BenhamouT Poynard
Dec 22, 1999·Journal of Viral Hepatitis·N Hayashi, E Mita
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M BerenguerJ Berenguer
Jul 20, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C S GrahamM J Koziel
Aug 2, 2001·Nature Medicine·D F MercerN M Kneteman
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y BenhamouUNKNOWN MultivirC Group
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Montserrat Garcia-RetortilloJuan Rodes
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karen L Lindsay
Nov 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrew I SuFrancis V Chisari
Mar 26, 2003·Cell Death and Differentiation·H Bantel, K Schulze-Osthoff
Apr 22, 2003·Nature Biotechnology·Eric C HsuChristopher D Richardson
Jun 18, 2003·The American Journal of Gastroenterology·Jean Michel PetitPatrick Hillon
Sep 13, 2003·Journal of Viral Hepatitis·J KountourasD Chatzopoulos
Dec 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jin YeMichael Gale
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bin GaoSvetlana Radaeva
Apr 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stefan WielandFrancis V Chisari
Oct 19, 2004·Annual Review of Microbiology·Naglaa H ShoukryChristopher M Walker
Nov 27, 2004·Journal of Virology·Catherine B BiggerRobert E Lanford
Feb 1, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B J Thomson, R G Finch
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Theo HellerT Jake Liang
Feb 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Kui LiStanley M Lemon
Feb 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eileen FoyMichael Gale
Mar 2, 2005·Nature Reviews. Immunology·Barbara Rehermann, Michelina Nascimbeni
Mar 16, 2005·The Journal of Biological Chemistry·Josephine C FerreonStanley M Lemon
Mar 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philip MeulemanGeert Leroux-Roels
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jin ZhongFrancis V Chisari
Jun 11, 2005·Science·Brett D LindenbachCharles M Rice
Jun 30, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daryl T-Y LauStanley M Lemon
Jul 19, 2005·Clinics in Liver Disease·Keyur PatelJohn G McHutchison
Aug 19, 2005·Nature·Brett D Lindenbach, Charles M Rice
Aug 19, 2005·Nature·Michael Gale, Eileen M Foy
Aug 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karla J HelbigMichael R Beard

❮ Previous
Next ❯

Citations

Jan 5, 2012·Fibrogenesis & Tissue Repair·Rebekka A HannivoortScott L Friedman
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Roberto J Carvalho-Filho, Olav Dalgard
Feb 15, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Deborah L DiamondMichael G Katze
Apr 4, 2009·Cellular Microbiology·Mehul S SutharDavid M Owen
Aug 18, 2009·Expert Review of Proteomics·Valeria R MasDaniel G Maluf
Oct 12, 2017·Scientific Reports·Luz M MedranoSalvador Resino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis